Literature DB >> 7506589

Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system.

D Beitner-Johnson1, E J Nestler.   

Abstract

Chronic morphine has been shown to decrease levels of neurofilaments (NFs) in the ventral tegmental area (VTA), which plays a critical role in the rewarding properties of morphine and other drugs of abuse. Since decreased levels of NFs are closely associated with a decrease in slow axonal transport, we studied the effect of chronic morphine on axonal transport in the VTA-nucleus accumbens (NAc) pathway. Chronic morphine decreased axonal transport from the VTA to the NAc by 50%. Chronic morphine did not alter axonal transport from the locus coeruleus to several of its projection areas, consistent with the lack of effect of chronic morphine on NFs in this brain region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506589     DOI: 10.1097/00001756-199310000-00014

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

2.  Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats.

Authors:  Ning-Ning Chu; Yan-Fang Zuo; Li Meng; David Yue-Wei Lee; Ji-Sheng Han; Cai-Lian Cui
Journal:  Brain Res       Date:  2007-09-20       Impact factor: 3.252

3.  Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.

Authors:  L Sklair-Tavron; W X Shi; S B Lane; H W Harris; B S Bunney; E J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.

Authors:  Michelle S Mazei-Robison; Ja Wook Koo; Allyson K Friedman; Carien S Lansink; Alfred J Robison; Monika Vinish; Vaishnav Krishnan; Seyun Kim; Michael A Siuta; Aurelio Galli; Kevin D Niswender; Raghu Appasani; Monika C Horvath; Rachel L Neve; Paul F Worley; Solomon H Snyder; Yasmin L Hurd; Joseph F Cheer; Ming-Hu Han; Scott J Russo; Eric J Nestler
Journal:  Neuron       Date:  2011-12-22       Impact factor: 17.173

Review 5.  Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons.

Authors:  Michelle S Mazei-Robison; Eric J Nestler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

6.  Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice.

Authors:  V A Boundy; S J Gold; C J Messer; J Chen; J H Son; T H Joh; E J Nestler
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 7.  Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.

Authors:  William A Carlezon; Christine Konradi
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

8.  Adult female rats' altered diurnal locomotor activity pattern following chronic methylphenidate treatment.

Authors:  T N Trinh; S R Kohllepel; P B Yang; K D Burau; N Dafny
Journal:  J Neural Transm (Vienna)       Date:  2013-07-27       Impact factor: 3.575

9.  Chronic oxycodone induces axonal degeneration in rat brain.

Authors:  Ruping Fan; Lisa M Schrott; Thomas Arnold; Stephen Snelling; Meghana Rao; Derrel Graham; Angela Cornelius; Nadejda L Korneeva
Journal:  BMC Neurosci       Date:  2018-03-23       Impact factor: 3.288

Review 10.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.